Volume 63, Issue 3, Pages (March 2013)

Slides:



Advertisements
Similar presentations
Volume 72, Issue 1, Pages (July 2017)
Advertisements

Volume 70, Issue 3, Pages (September 2016)
Volume 59, Issue 2, Pages (February 2011)
The PSA Era is not Over for Prostate Cancer
Volume 68, Issue 2, Pages (August 2015)
Volume 68, Issue 6, Pages (December 2015)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Testosterone Therapy in Men With Prostate Cancer
Global Trends in Testicular Cancer Incidence and Mortality
Volume 53, Issue 4, Pages (April 2008)
Volume 70, Issue 1, Pages (July 2016)
Volume 61, Issue 5, Pages (May 2012)
Volume 64, Issue 4, Pages (October 2013)
Volume 69, Issue 1, Pages (January 2016)
Volume 70, Issue 4, Pages (October 2016)
Volume 62, Issue 1, Pages (July 2012)
Prostate Cancer Epidemic in Sight?
Volume 68, Issue 1, Pages (July 2015)
Volume 59, Issue 2, Pages (February 2011)
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer  Sam Ladjevardi, Gabriel Sandblom,
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 68, Issue 5, Pages (November 2015)
Elizabeth K. Bancroft, Rosalind A. Eeles
Prostate Cancer Detection: A View of the Future
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
Volume 54, Issue 5, Pages (November 2008)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 69, Issue 3, Pages (March 2016)
Volume 71, Issue 6, Pages (June 2017)
Volume 73, Issue 4, Pages (April 2018)
Volume 63, Issue 4, Pages (April 2013)
Volume 66, Issue 6, Pages (December 2014)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Yuanshan Cui, Yong Zhang  European Urology 
Global Burden of Urologic Cancers, 1990–2013
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Relationship between Lower Urinary Tract Symptoms Frequency Assessed by the IPSS and Bothersomeness (SPI) among Men Older than 50 Years Old  P. Perrin,
Volume 53, Issue 4, Pages (April 2008)
Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?  Michel Bolla  European.
Volume 63, Issue 3, Pages (March 2013)
Volume 62, Issue 4, Pages (October 2012)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Volume 65, Issue 6, Pages (June 2014)
Richard C. Harkaway  European Urology Supplements 
Volume 50, Issue 3, Pages (September 2006)
Volume 50, Issue 5, Pages (November 2006)
CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 Studies 
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Testicular Cancer Variations in Time and Space in Europe
Volume 53, Issue 1, Pages (January 2008)
Prognostic Impact of Comorbidity in Patients with Bladder Cancer
Volume 75, Issue 3, Pages (March 2019)
Volume 72, Issue 1, Pages (July 2017)
European Urology is “Your” Journal
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
The Start-Up of the Platinum Journal: A Fascinating Challenge
Volume 75, Issue 5, Pages (May 2019)
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Economic Burden of Bladder Cancer Across the European Union
The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review  Fritz Schröder,
Volume 68, Issue 2, Pages (August 2015)
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Volume 54, Issue 3, Pages (September 2008)
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 63, Issue 3, Pages 585-587 (March 2013) Genetic Score Is an Objective and Better Measurement of Inherited Risk of Prostate Cancer than Family History  Jielin Sun, Rong Na, Fang-Chi Hsu, S. Lilly Zheng, Fredrik Wiklund, Lynn D. Condreay, Jeffery M. Trent, Jianfeng Xu  European Urology  Volume 63, Issue 3, Pages 585-587 (March 2013) DOI: 10.1016/j.eururo.2012.11.047 Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 1 (a) The distribution of family history and genetic score in five study populations: (left panel) the proportion of men with one family member or more affected with prostate cancer (PCa); (right panel) the mean genetic score. A chi-square test was used to test different proportions of positive family history between study populations and an analysis of variance was used to compare log-transformed mean genetic scores among different study populations. (b) The association of PCa risk with family history of PCa or genetic score in five study populations. The odds ratio (OR) was calculated from logistic regressions. Differences in OR among study populations were tested using an interaction term (family history by study populations or genetic score by study populations) in the logistic regression model. CI=confidence interval. European Urology 2013 63, 585-587DOI: (10.1016/j.eururo.2012.11.047) Copyright © 2012 European Association of Urology Terms and Conditions